Apollon Formularies (AQSE:APOL) Change In Receivables : £-0.09 Mil (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Change In Receivables?

Apollon Formularies's change in receivables for the quarter that ended in Jun. 2023 was £-0.09 Mil. It means Apollon Formularies's Accounts Receivable increased by £0.09 Mil from Jun. 2022 to Jun. 2023 .

Apollon Formularies's change in receivables for the fiscal year that ended in Dec. 2021 was £-0.03 Mil. It means Apollon Formularies's Accounts Receivable increased by £0.03 Mil from Dec. 2020 to Dec. 2021 .

Apollon Formularies's Accounts Receivable for the quarter that ended in Jun. 2023 was £0.68 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Apollon Formularies's Days Sales Outstanding for the six months ended in Jun. 2023 was 2,574.01.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Apollon Formularies's liquidation value for the six months ended in Jun. 2023 was £-1.28 Mil.

Apollon Formularies Change In Receivables Historical Data

The historical data trend for Apollon Formularies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Change In Receivables Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Change In Receivables

Get a 7-Day Free Trial

0.13

0.04

0.26

-0.03

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Change In Receivables	Get a 7-Day Free Trial											0.14	-0.08	0.06	-0.29	-0.09

Apollon Formularies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.09 Mil.

Apollon Formularies (AQSE:APOL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Apollon Formularies's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.677	/	0.048	*	91
=	2,574.01

2. In Ben Graham's calculation of liquidation value, Apollon Formularies's accounts receivable are only considered to be worth 75% of book value:

Apollon Formularies's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.051	-	1.842	+	0.75 * 0.677	+	0.5 * 0
=	-1.28

Apollon Formularies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.